ATYR

aTyr Pharma
ATYR

Overview Fund Activity

41 hedge funds and large institutions have $105M invested in aTyr Pharma in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
41
Holders Change
-6
Holders Change %
-12.77%
% of All Funds
0.65%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
13
Reduced
12
Closed
12
Calls
$445K
Puts
$1.2M
Net Calls
-$757K
Net Calls Change
-$710K

Top Buyers

1
TM
1
Tikvah Management
North Carolina
$7.23M
2
TI
2
Telemetry Investments
New York
$1.51M
3
Alyeska Investment Group
3
Alyeska Investment Group
Illinois
$4.07M
4
SCM
4
Stonepine Capital Management
Oregon
$3.22M
5
State Street
5
State Street
Massachusetts
$444K

Top Sellers

1
EI
1
EAM Investors
California
$0
2
Two Sigma Investments
2
Two Sigma Investments
New York
$1.26M
3
EGI
3
EAM Global Investors
California
$0
4
Two Sigma Advisers
4
Two Sigma Advisers
New York
$1.06M
5
VA
5
VR Adviser
New York
$7.48M
Name Holding Trade Value Shares
Change 		Shares
Change %
Qube Research & Technologies (QRT)
51
Qube Research & Technologies (QRT)
United Kingdom
– -$87K -11,665 Closed
1 2
3